A young advocate emphasizes the importance of communication between parents and their children about an ovarian cancer diagnosis.
“The privilege of caring for these patients and their families through one of the most difficult times in their lives has helped us redefine what compassionate care truly means,” wrote Justin Kelly, BSN, RN, CCRN, RHIA in this essay nominating Brenda Hamer, BSN, RN, CCRN, OCN for CURE®’s 2019 Extraordinary Healer® Award.
When my feline companion developed cancer, quality of life became more important than quantity of days.
When I got CURE®’s spring issue in the mail; I couldn’t put it down! Now that I’m going into my 10th year of survival from a highly aggressive cancer; it’s my turn to write about my experiences based on the stories in this issue.
Texas joins nine other states in requiring health insurance providers to cover oral chemo the same as I.V. treatments.
At its best, hospice provides time and space for end-of-life conversations.
Dr. Debu Tripathy, editor-in-chief of CURE magazine, discusses the advancements made in small cell lung cancer.
An Extraordinary Healer essay honoring TINA PURSGLOVE, RN, OCN [THE OHIO STATE UNIVERSITY WEXNER MEDICAL CENTER JAMES CANCER HOSPITAL, COLUMBUS, OHIO]
Preventive measures are being sought for cervical and ovarian cancers.
Not every cancer patient seeks, needs or wants a second opinion.
Share your cancer story, says news anchor and survivor Amy Robach.
An essay honoring Alison Moore, RN, BSN [Chattanooga's Program In Women's Oncology In Whitwell, Tennessee]
A cautious approach to supplements and a discussion with your physician while taking them during treatment is a must.
Dr. D. Ross Camidge shares with CURE® a diary of his dealings with the COVID-19 pandemic at the University of Colorado Cancer Center as life changed for his team and his patients.
The understanding of genetic mutations, like tumors that are microsatellite instability-high (MSI-H), and the therapies that go along with them is transforming the world of colorectal cancer, according to John Marshall, M.D.
While Jakafi has been providing promising outcomes so far, there are still some side effects that patients and providers should look out for.
Once again, when it comes to surgery to treat breast cancer, less has been shown to be more.
Finalist essay from the 2009 Extraordinary Healer Award contest.
"We already know how extraordinary she is, and it's time to tell everyone else."
Sandra Allen-Bard, MSN, ANCC, AOCNP, of Weill Cornell Medical Center, discusses the impact myeloproliferative neoplasms can have on patients' quality of life.
ROS1 may be a rare mutation in the cancer world, but a group of ROS1 patients have taken it upon themselves to search for answers.
A gynecologic-oncology clinical nurse specialist and one of this year’s CURE Ovarian Cancer Heroes discussed the lack of resources for patients with ovarian cancer and the need for more research.
Jubilee Brown, M.D., obstetrician-gynecologist, Levine Cancer Institute, Carolinas HealthCare System, discusses genetic counseling for patients with breast and ovarian cancer.
“At 34, I have another chance to live the rest of my life with a consciousness that there's great purpose in the pain.”
Finalist essay for CURE's 2013 Extraordinary Healer Award for Oncology Nursing.